Sabby Management »

Aim Immunotech shares owned by Sabby Management

Quarter-by-quarter ownership of Aim Immunotech (AIM) shares owned by Sabby Management from 13F filings

Historical chart of Sabby Management investment in Aim Immunotech

Tip: Access up to 7 years of quarterly data

All positions including Aim Immunotech held by Sabby Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aim Immunotech by Sabby Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $79k 29k 2.74

More positions owned by Sabby Management

Ishares Tr Etf Call Option
Spdr S&p 500 Etf Etf Put Option
Ishares Tr Etf Put Option
Big Tree Cloud Holdings SHS (DSY)
Spdr S&p 500 Etf Etf Call Option
Eos Energy Enterprises Put Option
Volcon (EMPD)
Pop Culture Group SHS (CPOP)
Eve Holding Ord (EVEX)
Can-fite Biopharma Adr (CANF)
Lyra Therapeutics (LYRA)
Oceanpal
Lm Fdg Amer (LMFA)
Bioaffinity Technologies
U Power Cl A (UCAR)

View all positions for Sabby Management

Top funds holding Aim Immunotech

DRW Holdings
Sabby Management
Vanguard Group
Geode Capital Management
Morgan Stanley
UBS Group
Community Bank
Pnc Financial Services
Advisor Group Holdings
Hoey Investments
Harbour Investments
Wells Fargo & Company
Steward Partners Investment Advisory
Farther Finance Advisors

View all funds holding Aim Immunotech